Predictions
L3Harris Technologies Inc.
Start price
Target price
Perf. (%)
€155.00
15.08.20
15.08.20
-
29.10.20
29.10.20
-9.68%
29.10.20
29.10.20
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Top 10 in its market
positive Cash Flow expected
Paychex Inc.
Start price
Target price
Perf. (%)
€62.76
14.08.20
14.08.20
-
15.10.20
15.10.20
12.94%
15.10.20
15.10.20
High dividend yield expected
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Corestate Capital Holding SA
Start price
Target price
Perf. (%)
€15.31
14.08.20
14.08.20
-
15.10.20
15.10.20
1.96%
15.10.20
15.10.20
Business model of the past or high risk
Probably not worthwhile Investment
MSCI Inc. A
Start price
Target price
Perf. (%)
€301.10
14.08.20
14.08.20
-
15.10.20
15.10.20
0.20%
15.10.20
15.10.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Low dividend yield expected
Infineon Technologies AG
Start price
Target price
Perf. (%)
€21.75
14.08.20
14.08.20
-
18.10.20
18.10.20
26.48%
18.10.20
18.10.20
ROE higher than 15% per year
Very Future proof/growth oriented business model
Low dividend yield expected
Apple Inc.
Start price
Target price
Perf. (%)
€97.60
14.08.20
14.08.20
€140.00
04.11.21
04.11.21
34.75%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Abbott Laboratories
Start price
Target price
Perf. (%)
€85.17
14.08.20
14.08.20
€120.00
04.11.21
04.11.21
31.44%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth > 30% per year expected
Alibaba Group Holding Ltd ADR
Start price
Target price
Perf. (%)
€216.50
14.08.20
14.08.20
€265.00
04.11.21
04.11.21
-33.86%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Undervalued
Fuchs Petrolub SE ST
Start price
Target price
Perf. (%)
€37.84
14.08.20
14.08.20
€50.00
04.11.21
04.11.21
21.25%
06.11.20
06.11.20
Could be worthwhile Investment >10% per year
Known brand
Good culture
L'Oreal S.A.
Start price
Target price
Perf. (%)
€280.70
14.08.20
14.08.20
€300.00
04.11.21
04.11.21
46.06%
05.11.21
05.11.21
ROE higher than 10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Small challenges to pay loans and raise capital
Teladoc Health Inc
Start price
Target price
Perf. (%)
€164.88
14.08.20
14.08.20
€210.00
04.11.21
04.11.21
24.94%
22.01.21
22.01.21
Future proof or reliable business model
Top 10 in its market
Innovative
Growths faster than the competition
Zynga Inc.
Start price
Target price
Perf. (%)
€7.92
14.08.20
14.08.20
€10.00
25.08.20
25.08.20
-2.53%
25.08.20
25.08.20
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
NVIDIA Corp.
Start price
Target price
Perf. (%)
€2.45
13.08.20
13.08.20
€3.19
04.11.21
04.11.21
14.63%
22.01.21
22.01.21
Small cyclical dependencies
Could be worthwhile Investment >10% per year
Growths faster than the competition
Innovative
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€2.66
13.08.20
13.08.20
€25.00
04.11.21
04.11.21
975.97%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Zalando SE
Start price
Target price
Perf. (%)
€68.26
13.08.20
13.08.20
€87.00
12.10.20
12.10.20
25.40%
12.10.20
12.10.20
Revenue growth >5% per year expected
Medium risks for its business
Top 10 in its market
Well known brand
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€10.32
13.08.20
13.08.20
€9.00
07.09.20
07.09.20
-5.66%
07.09.20
07.09.20
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Deutsche Telekom AG
Start price
Target price
Perf. (%)
€15.41
13.08.20
13.08.20
€17.50
04.11.21
04.11.21
7.74%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Seelos Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.87
13.08.20
13.08.20
€1.00
31.10.20
31.10.20
-43.94%
31.10.20
31.10.20
India Globalization Capital
Start price
Target price
Perf. (%)
€3.03
13.08.20
13.08.20
€0.000
22.08.20
22.08.20
-63.66%
22.08.20
22.08.20
Risky Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
overvalued
CytoTools AG
Start price
Target price
Perf. (%)
€10.20
12.08.20
12.08.20
€26.00
04.11.21
04.11.21
56.86%
13.04.21
13.04.21
Could be very worthwhile Investment >20% year
Differentiated customer and product portfolio